{"result": "(\"entity\"<|>NILUTAMIDE<|>ORGANIZATION<|>Nilutamide is a compound classified as an Androgen Receptor Antagonist used to treat prostate cancer, with side effects including abdominal pain and alopecia.)\n##\n(\"entity\"<|>ESTRADIOL<|>ORGANIZATION<|>Estradiol is a compound classified as an Estrogen Receptor Agonist used to treat prostate cancer, with side effects including abdominal cramps and anaphylactic shock.)\n##\n(\"entity\"<|>PREDNISONE<|>ORGANIZATION<|>Prednisone is a compound classified as a Corticosteroid Hormone Receptor Agonist used to treat prostate cancer, with side effects including abdominal distension and adrenal insufficiency.)\n##\n(\"entity\"<|>EPIRUBICIN<|>ORGANIZATION<|>Epirubicin is a compound classified as a Topoisomerase Inhibitor used to treat prostate cancer, with side effects including lactic acidosis and agranulocytosis.)\n##\n(\"entity\"<|>ESTRONE<|>ORGANIZATION<|>Estrone is a compound with no specific pharmacologic class mentioned, used to treat prostate cancer, with side effects including abdominal cramps and asthma.)\n##\n(\"entity\"<|>ETOPOSIDE<|>ORGANIZATION<|>Etoposide is a compound classified as a Topoisomerase Inhibitor used to treat prostate cancer, with side effects including abdominal pain and agranulocytosis.)\n##\n(\"entity\"<|>ETHINYL ESTRADIOL<|>ORGANIZATION<|>Ethinyl Estradiol is a compound classified as an Estrogen Receptor Agonist used to treat prostate cancer, with side effects including anxiety and breast disorder.)\n##\n(\"entity\"<|>CONJUGATED ESTROGENS<|>ORGANIZATION<|>Conjugated Estrogens is a compound classified as an Estrogen Receptor Agonist used to treat prostate cancer, with side effects including acidosis and anaphylactic shock.)\n##\n(\"entity\"<|>ABIRATERONE<|>ORGANIZATION<|>Abiraterone is a compound with no specific pharmacologic class mentioned, used to treat prostate cancer, with side effects including arrhythmia and chest pain.)\n##\n(\"entity\"<|>MITOXANTRONE<|>ORGANIZATION<|>Mitoxantrone is a compound classified as a Topoisomerase Inhibitor used to treat prostate cancer, with side effects including anxiety and arrhythmia.)\n##\n(\"relationship\"<|>NILUTAMIDE<|>ESTRADIOL<|>Both Nilutamide and Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>PREDNISONE<|>Both Nilutamide and Prednisone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>EPIRUBICIN<|>Both Nilutamide and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>ETOPOSIDE<|>Both Nilutamide and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>ETHINYL ESTRADIOL<|>Both Nilutamide and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>CONJUGATED ESTROGENS<|>Both Nilutamide and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>ABIRATERONE<|>Both Nilutamide and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>NILUTAMIDE<|>MITOXANTRONE<|>Both Nilutamide and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>PREDNISONE<|>Both Estradiol and Prednisone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>EPIRUBICIN<|>Both Estradiol and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>ETOPOSIDE<|>Both Estradiol and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>ETHINYL ESTRADIOL<|>Both Estradiol and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>CONJUGATED ESTROGENS<|>Both Estradiol and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>ABIRATERONE<|>Both Estradiol and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ESTRADIOL<|>MITOXANTRONE<|>Both Estradiol and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>PREDNISONE<|>EPIRUBICIN<|>Both Prednisone and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>PREDNISONE<|>ETOPOSIDE<|>Both Prednisone and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>PREDNISONE<|>ETHINYL ESTRADIOL<|>Both Prednisone and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>PREDNISONE<|>CONJUGATED ESTROGENS<|>Both Prednisone and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>PREDNISONE<|>ABIRATERONE<|>Both Prednisone and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>PREDNISONE<|>MITOXANTRONE<|>Both Prednisone and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>EPIRUBICIN<|>ETOPOSIDE<|>Both Epirubicin and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>EPIRUBICIN<|>ETHINYL ESTRADIOL<|>Both Epirubicin and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>EPIRUBICIN<|>CONJUGATED ESTROGENS<|>Both Epirubicin and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>EPIRUBICIN<|>ABIRATERONE<|>Both Epirubicin and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>EPIRUBICIN<|>MITOXANTRONE<|>Both Epirubicin and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETOPOSIDE<|>ETHINYL ESTRADIOL<|>Both Etoposide and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETOPOSIDE<|>CONJUGATED ESTROGENS<|>Both Etoposide and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETOPOSIDE<|>ABIRATERONE<|>Both Etoposide and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETOPOSIDE<|>MITOXANTRONE<|>Both Etoposide and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETHINYL ESTRADIOL<|>CONJUGATED ESTROGENS<|>Both Ethinyl Estradiol and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETHINYL ESTRADIOL<|>ABIRATERONE<|>Both Ethinyl Estradiol and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ETHINYL ESTRADIOL<|>MITOXANTRONE<|>Both Ethinyl Estradiol and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>CONJUGATED ESTROGENS<|>ABIRATERONE<|>Both Conjugated Estrogens and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>CONJUGATED ESTROGENS<|>MITOXANTRONE<|>Both Conjugated Estrogens and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n##\n(\"relationship\"<|>ABIRATERONE<|>MITOXANTRONE<|>Both Abiraterone and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: dominal pain, Pancreatitis acute, Adenoma benign, Agranulocytosis, Albuminuria, Alopecia, Anaphylactic shock, Anaemia, Aplastic anaemia, Angina pectoris\n\nCompound name: Nilutamide\nPharmacologic class: Androgen Receptor Antagonists\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal pain, Alopecia, Anaemia, Angina pectoris, Anorexia, Arthritis, Asthenia, Back pain, Chest pain, Constipation\n\nCompound name: Estradiol\nPharmacologic class: Estrogen Receptor Agonists\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal cramps, Abdominal distension, Abdominal pain, Congenital anomaly, Alopecia, Amenorrhoea, Amnesia, Anaphylactic shock, Angioedema, Anxiety\n\nCompound name: Prednisone\nPharmacologic class: Corticosteroid Hormone Receptor Agonists\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Abscess, Pancreatitis acute, Adrenal insufficiency, Alkalosis, Alopecia, Amenorrhoea, Amnesia, Anaphylactic shock\n\nCompound name: Epirubicin\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Abscess, Lactic acidosis, Agranulocytosis, Albuminuria, Alopecia, Amblyopia, Amenorrhoea, Anaphylactic shock\n\nCompound name: Estrone\nPharmacologic class: None\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal cramps, Abdominal distension, Abdominal pain, Anaphylactic shock, Angioedema, Arthralgia, Asthma, Breast cancer, Vaginal moniliasis, Chorea\n\nCompound name: Etoposide\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Anaphylactic shock, Anaemia, Anorexia, Apnoea, Ascites, Asthenia, Back pain\n\nCompound name: Ethinyl Estradiol\nPharmacologic class: Estrogen Receptor Agonists\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Alopecia, Amenorrhoea, Angioedema, Anxiety, Asthenia, Back pain, Mental disorder, Breast disorder\n\nCompound name: Conjugated Estrogens\nPharmacologic class: Estrogen Receptor Agonists\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal cramps, Abdominal distension, Abdominal pain, Abscess, Acidosis, Alkalosis, Alopecia, Amenorrhoea, Anaphylactic shock, Angioedema\n\nCompound name: Abiraterone\nPharmacologic class: None\nEffect on Prostate Cancer: Treat\nSide effect: Anaemia, Arrhythmia, Asthenia, Mental disorder, Chest pain, Infection, Connective tissue disorder, Constipation, Contusion, Cough\n\nCompound name: Mitoxantrone\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Prostate Cancer: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Amenorrhoea, Anaphylactic shock, Anaemia, Anorexia, Anxiety, Arrhythmia, Arthralgia\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}